This report explores how the GLP-1 weight loss drug trend is changing consumer eating patterns and may ultimately impact your business.

By 2030, 9% of the US population is expected to be using weight loss drugs. As a leader in the food, beverage, and wellness industries, how can you adapt and innovate in response to this seismic dietary shift?

With exclusive insights from the healthcare professionals working directly with weight loss drug patients, this report explores the change in consumption of various food and drink categories among this growing consumer segment.

This report highlights:

• The expected global implications of this weight loss drug trend
• The influence of these drugs on dietary eating patterns
• The potential impact on consumer purchasing decisions

Get a preview of the insights you need to make strategic decisions across your business, from nutrition to marketing to corporate strategy.

Please fill the below form to download

Download